Evolent Health, Inc (EVH): Price and Financial Metrics
GET POWR RATINGS... FREE!
EVH POWR Grades
- EVH scores best on the Growth dimension, with a Growth rank ahead of 99.8% of US stocks.
- The strongest trend for EVH is in Growth, which has been heading up over the past 179 days.
- EVH ranks lowest in Value; there it ranks in the 28th percentile.
EVH Stock Summary
- The price/operating cash flow metric for Evolent Health Inc is higher than 93.25% of stocks in our set with a positive cash flow.
- With a year-over-year growth in debt of -22.05%, Evolent Health Inc's debt growth rate surpasses only 18.24% of about US stocks.
- As for revenue growth, note that EVH's revenue has grown -11.2% over the past 12 months; that beats the revenue growth of only 10.28% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Evolent Health Inc, a group of peers worth examining would be IMAC, MEG, HLIO, HMTV, and MNSB.
- EVH's SEC filings can be seen here. And to visit Evolent Health Inc's official web site, go to www.evolenthealth.com.
EVH Valuation Summary
- In comparison to the median Technology stock, EVH's price/sales ratio is 59.63% lower, now standing at 2.2.
- EVH's price/earnings ratio has moved up 3.2 over the prior 76 months.
- Over the past 76 months, EVH's price/sales ratio has gone NA NA.
Below are key valuation metrics over time for EVH.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EVH | 2021-09-01 | 2.2 | 3.5 | -30.6 | -54.1 |
EVH | 2021-08-31 | 2.2 | 3.5 | -30.2 | -53.6 |
EVH | 2021-08-30 | 2.2 | 3.5 | -30.2 | -53.4 |
EVH | 2021-08-27 | 2.2 | 3.5 | -30.0 | -53.1 |
EVH | 2021-08-26 | 2.1 | 3.4 | -29.5 | -52.2 |
EVH | 2021-08-25 | 2.1 | 3.4 | -29.4 | -52.2 |
EVH Growth Metrics
- The 5 year price growth rate now stands at -32.61%.
- Its 4 year cash and equivalents growth rate is now at -43.2%.
- The 3 year price growth rate now stands at 6.92%.

The table below shows EVH's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 907.957 | 38.747 | -37.601 |
2021-09-30 | 931.522 | -40.76 | -46.579 |
2021-06-30 | 973.644 | -105.76 | -70.887 |
2021-03-31 | 990.219 | -43.847 | -265.301 |
2020-12-31 | 1,022.433 | -16.225 | -334.246 |
2020-09-30 | 987.035 | 9.813 | -517.717 |
EVH's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EVH has a Quality Grade of D, ranking ahead of 14.15% of graded US stocks.
- EVH's asset turnover comes in at 0.713 -- ranking 221st of 563 Business Services stocks.
- EVOL, GLOB, and AKAM are the stocks whose asset turnover ratios are most correlated with EVH.
The table below shows EVH's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.713 | 0.254 | -0.052 |
2021-06-30 | 0.726 | 0.244 | -0.113 |
2021-03-31 | 0.742 | 0.245 | -0.547 |
2020-12-31 | 0.746 | 0.228 | -0.601 |
2020-09-30 | 0.704 | 0.220 | -0.869 |
2020-06-30 | 0.636 | 0.223 | -0.795 |
EVH Price Target
For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $28.33 | Average Broker Recommendation | 1.43 (Moderate Buy) |
EVH Stock Price Chart Interactive Chart >
EVH Price/Volume Stats
Current price | $29.43 | 52-week high | $34.60 |
Prev. close | $28.96 | 52-week low | $18.33 |
Day low | $28.43 | Volume | 719,000 |
Day high | $29.85 | Avg. volume | 687,250 |
50-day MA | $29.52 | Dividend yield | N/A |
200-day MA | $27.29 | Market Cap | 2.70B |
Evolent Health, Inc (EVH) Company Bio
Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.
Latest EVH News From Around the Web
Below are the latest news stories about Evolent Health Inc that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Why Shares of Evolent Health Jumped 22% ThursdayThe company's stock climbed nearly $5 higher per share on Thursday over its closing price on Wednesday. |
Evolent Health (EVH) Q4 2021 Earnings Call TranscriptWelcome to Evolent Health's earnings conference call for the fourth quarter and year ended December 31, 2021. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer. |
Evolent Health Announces Fourth Quarter and Full Year 2021 ResultsEvolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter and full year ended December 31, 2021. |
Zendesk (ZEN) Misses Q4 Earnings EstimatesZendesk (ZEN) delivered earnings and revenue surprises of -11.11% and 1.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Digital Turbine (APPS) Q3 Earnings and Revenues Surpass EstimatesDigital Turbine (APPS) delivered earnings and revenue surprises of 13.95% and 6.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
EVH Price Returns
1-mo | 0.96% |
3-mo | 26.20% |
6-mo | 3.12% |
1-year | 47.15% |
3-year | 102.97% |
5-year | 26.04% |
YTD | 6.36% |
2021 | 72.61% |
2020 | 77.13% |
2019 | -54.64% |
2018 | 62.20% |
2017 | -16.89% |
Continue Researching EVH
Want to do more research on Evolent Health Inc's stock and its price? Try the links below:Evolent Health Inc (EVH) Stock Price | Nasdaq
Evolent Health Inc (EVH) Stock Quote, History and News - Yahoo Finance
Evolent Health Inc (EVH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...